236 related articles for article (PubMed ID: 33176509)
1. An analysis of genetic targets for guiding clinical management of follicular lymphoma.
Alonso-Alonso R; Rodriguez M; Morillo D; Cordoba R; Piris MA
Expert Rev Hematol; 2020 Dec; 13(12):1361-1372. PubMed ID: 33176509
[No Abstract] [Full Text] [Related]
2. Follicular lymphoma: evolving therapeutic strategies.
Kahl BS; Yang DT
Blood; 2016 Apr; 127(17):2055-63. PubMed ID: 26989204
[TBL] [Abstract][Full Text] [Related]
3. Follicular lymphoma: 2014 update on diagnosis and management.
Freedman A
Am J Hematol; 2014 Apr; 89(4):429-36. PubMed ID: 24687887
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory Agents in Follicular Lymphoma.
Ysebaert L; Morschhauser F
Hematol Oncol Clin North Am; 2020 Aug; 34(4):715-726. PubMed ID: 32586576
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of follicular lymphoma.
Kridel R; Sehn LH; Gascoyne RD
J Clin Invest; 2012 Oct; 122(10):3424-31. PubMed ID: 23023713
[TBL] [Abstract][Full Text] [Related]
6. Pathology, pathogenesis and molecular genetics of follicular NHL.
Leich E; Ott G; Rosenwald A
Best Pract Res Clin Haematol; 2011 Jun; 24(2):95-109. PubMed ID: 21658611
[TBL] [Abstract][Full Text] [Related]
7. Double-hit follicular lymphoma with MYC and BCL2 translocations: a study of 7 cases with a review of literature.
Miao Y; Hu S; Lu X; Li S; Wang W; Medeiros LJ; Lin P
Hum Pathol; 2016 Dec; 58():72-77. PubMed ID: 27544800
[TBL] [Abstract][Full Text] [Related]
8. Navigating the Heterogeneity of Follicular Lymphoma and its Many Variants: An Updated Approach to Diagnosis and Classification.
Louissaint A
Surg Pathol Clin; 2023 Jun; 16(2):233-247. PubMed ID: 37149358
[TBL] [Abstract][Full Text] [Related]
9. [The role of translocations involving c-MYC/8q24, BCL2/18q21 and/or BCL6/3q27 genes in patients with follicular lymphoma. Retrospective analysis of single - centre data].
Misyurina AE; Kravchenko SK; Kovrigina AM; Magomedova AU; Plastinina LV; Obukhova TN; Misyurin AV; Misyurin VA; Grebenuk LA; Babaeva FE; Baryakh EA; Vorobiev AI
Ter Arkh; 2019 Jul; 91(7):52-62. PubMed ID: 32598736
[TBL] [Abstract][Full Text] [Related]
10. [Follicular lymphoma].
Illés A; Krenács L; Borbényi Z
Orv Hetil; 2003 Nov; 144(46):2253-61. PubMed ID: 14702920
[TBL] [Abstract][Full Text] [Related]
11. Molecular insights into the immunopathogenesis of follicular lymphoma.
Stamatopoulos K; Kosmas C; Belessi C; Stavroyianni N; Kyriazopoulos P; Papadaki T
Immunol Today; 2000 Jun; 21(6):298-305. PubMed ID: 10825742
[TBL] [Abstract][Full Text] [Related]
12. Treatment of follicular non-Hodgkin's lymphoma.
Maloney DG
Curr Hematol Rep; 2005 Jan; 4(1):39-45. PubMed ID: 15610658
[TBL] [Abstract][Full Text] [Related]
13. Targeting indolent non-Hodgkin lymphoma.
Leslie LA; Skarbnik AP; Bejot C; Stives S; Feldman TA; Goy AH
Expert Rev Hematol; 2017 Apr; 10(4):299-313. PubMed ID: 28277849
[TBL] [Abstract][Full Text] [Related]
14. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.
Papajík T; Jedlicková K; Kriegová E; Jarosová M; Raida L; Faber E; Hubácek J; Vondráková J; Pikalová Z; Indrák K
Neoplasma; 2001; 48(6):501-5. PubMed ID: 11949845
[TBL] [Abstract][Full Text] [Related]
15. The role of obinutuzumab in the management of follicular lymphoma.
O'Nions J; Townsend W
Future Oncol; 2019 Nov; 15(31):3565-3578. PubMed ID: 31538821
[TBL] [Abstract][Full Text] [Related]
16. Targeted Therapies for Follicular Lymphoma.
Girard J; Karimi Y; Carty S; Wilcox R; Kaminiski M; Malek S; Phillips T
Curr Hematol Malig Rep; 2021 Feb; 16(1):25-31. PubMed ID: 33754292
[TBL] [Abstract][Full Text] [Related]
17. The heterogeneity of follicular lymphomas: from early development to transformation.
Xerri L; Dirnhofer S; Quintanilla-Martinez L; Sander B; Chan JK; Campo E; Swerdlow SH; Ott G
Virchows Arch; 2016 Feb; 468(2):127-39. PubMed ID: 26481245
[TBL] [Abstract][Full Text] [Related]
18. Clinical impact of molecular features in diffuse large B-cell lymphoma and follicular lymphoma.
Pon JR; Marra MA
Blood; 2016 Jan; 127(2):181-6. PubMed ID: 26447189
[TBL] [Abstract][Full Text] [Related]
19. Checkpoint Inhibitors and Other Immune Therapies for Hodgkin and Non-Hodgkin Lymphoma.
Matsuki E; Younes A
Curr Treat Options Oncol; 2016 Jun; 17(6):31. PubMed ID: 27193488
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy-sparing treatment strategies for follicular lymphoma: current options and future directions.
Ng SY; Abramson JS
Curr Opin Hematol; 2016 Jul; 23(4):371-6. PubMed ID: 27213499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
